TY  - RPRT
TI  - CCT-217: A Landmark Gene Silencing Therapeutic for Weight Loss That Enhances Lean Mass Composition, Reduces Visceral, Subcutaneous Fat and Restores Metabolic Health in Obesity through Browning
AU  - Reddy, R.
AU  - Singh, I.
PY  - 2024
DO  - 10.1101/2024.12.30.630715
UR  - https://www.biorxiv.org/content/10.1101/2024.12.30.630715v1
ID  - 10.1101/2024.12.30.630715
ER  -